🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To investigate the dose-exposure-response relationship of insulin glulisine...
Status
Completed
Location
Sanofi-Aventis
Start Date
2004-01
Trial ID
NCT00368394
Treatments Being Tested
To collect effectiveness and safety data during the treatment with Apidra g...
Status
Completed
Location
Sanofi-Aventis
Start Date
2005-08
Trial ID
NCT00489190
Treatments Being Tested
Primary Objective: To demonstrate the superiority of the insulin glargine/...
Status
Completed
Location
Investigational Site Number 01
Start Date
2018-06-19
Trial ID
NCT03529123
To evaluate the efficacy (in terms of change HbA1c from baseline to endpoin...
Status
Completed
Location
Sanofi-aventis
Start Date
2004-09
Trial ID
NCT00546702
Treatments Being Tested
To evaluate the efficacy (in terms of change HbA1c from baseline to endpoin...
Status
Completed
Location
Sanofi-Aventis
Start Date
2004-09
Trial ID
NCT00545337
Treatments Being Tested
* To evaluate the superiority in the efficacy of HMR1964 and OHA combinatio...
Status
Completed
Location
Sanofi-Aventis
Start Date
2003-12
Trial ID
NCT00290927
Treatments Being Tested
Primary Objective: \- To compare lixisenatide versus insulin glulisine in ...
Status
Completed
Location
Investigational Site Number 840043
Start Date
2013-01
Trial ID
NCT01768559
The purpose of this study is to compare the safety of HMR 1964 and insulin ...
Status
Completed
Location
Hospital de Rangueil
Start Date
2002-05
Trial ID
NCT00046150
Treatments Being Tested
Primary Objective: To demonstrate bioequivalence between insulin glulisine...
Status
Completed
Location
Investigational Site Number 276001
Start Date
2017-02-17
Trial ID
NCT02910518
Treatments Being Tested
Primary Objective: To evaluate the efficacy and the safety of insulin glul...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2009-07
Trial ID
NCT00964574
Treatments Being Tested